Molecular Detection of Human Cytomegalovirus in Patients with Recurrent Respiratory Tract Infections
European Multidisciplinary Journal of Modern Science · 30.10.2026 · 28 (4) · 283-298
DOI: 10.51699/dgxh1544 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Multidisciplinary Journal of Modern Science, online erschienen am 30.10.2026. Verfasst von Suad Hammood Al Bashar. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recurrent LRTIs are a recurring clinical and diagnostic conundrum in paediatric and adult pulmonary medicine, often leading to chronic, progressive decreases in respiratory function and/or cumulative parenchymal damage. Human cytomegalovirus (HCMV) is well known as an opportunistic pathogen in classical immunosuppressed conditions but recently, local reactivation of the virus in the lower respiratory tract of patients with chronic pulmonary inflammation without the presence of the classical type of immunodeficiency is increasingly suggested as a possible mechanism. This prospective cross-sectional observational study was carried out to assess the molecular detection and viral load of HCMV DNA in lower respiratory tract specimens in relation to matched plasma specimens, quantify local inflammatory markers (interleukin 6 and tumor necrosis factor alpha) and detect co-infecting viral/bacterial pathogens. One hundred and twenty (120) patients with documented recurrent lower respiratory tract infection (LRTI) were evaluated by diagnostic bronchoscopy or deep tissue samples of lower respiratory tract. Alongside the quantitative microbiology and cytokine immunoassays, automated nucleic acid extraction and real-time quantitative polymerase chain reaction (qPCR) were done. HCMV DNA was identified in 41.7% (50/120) of lower respiratory tract specimens, while plasma DNAemia was only found in 12.5% (15/120); this is characteristic of a compartmentalized pulmonary shedding profile. Local interleukin 6 levels were significantly elevated in endobronchial HCMV detection as compared to HCMV negative patients. The present study results suggest that HCMV shedding in the lungs is common during recurrent RTIs and that the use of direct molecular quantification of HCMV in lower respiratory samples should be considered as a tool to make clinical decisions, not only serological and plasma based.
Zitieren
APA
Bashar, S. H. A. (2026). Molecular Detection of Human Cytomegalovirus in Patients with Recurrent Respiratory Tract Infections. European Multidisciplinary Journal of Modern Science, 28(4), 283-298. https://doi.org/10.51699/dgxh1544
Vancouver
Bashar SHA. Molecular Detection of Human Cytomegalovirus in Patients with Recurrent Respiratory Tract Infections. European Multidisciplinary Journal of Modern Science. 2026;28(4):283-298. doi:10.51699/dgxh1544
BibTeX
@article{Bashar2026,
author = {Bashar, Suad Hammood Al},
title = {Molecular Detection of Human Cytomegalovirus in Patients with Recurrent Respiratory Tract Infections},
journal = {European Multidisciplinary Journal of Modern Science},
year = {2026},
volume = {28},
number = {4},
pages = {283--298},
doi = {10.51699/dgxh1544}
}
EUVIMED